Covid 19 Research using Clinical Trials (Home Page)
Extracorporeal membrane oxygenationWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (1)
|
Name (Synonyms) |
Correlation |
drug233 | Asynchronies detection Wiki | 1.00 |
Correlated MeSH Terms (4)
Correlated HPO Terms (0)
|
Name (Synonyms) |
Correlation |
There is one clinical trial.
Clinical Trials
This study aims to investigate outcomes and predictors of outcome after extracorporeal
membrane oxygenation (ECMO) therapy for severe acute respiratory syndrome (ARDS) in COVID-19
patients.
Primary Outcomes
Measure: In-hospital mortality Time: During index hospital stay follow-up until 1 year after ECMO initiation
Secondary Outcomes
Measure: Death on ECMO Time: During index hospital stay follow-up until 1 year after ECMO initiation
Measure: Stroke Time: During index hospital stay follow-up until 1 year after ECMO initiation
Measure: Blood stream infection Time: During index hospital stay follow-up until 1 year after ECMO initiation
Measure: Lung complications requiring surgical treatment Time: During index hospital stay follow-up until 1 year after ECMO initiation
Measure: Blood transfusion Time: During index hospital stay follow-up until 1 year after ECMO initiation
Measure: Acute kidney injury Time: During index hospital stay follow-up until 1 year after ECMO initiation
Measure: Duration of mechanical ventilation Time: During index hospital stay follow-up until 1 year after ECMO initiation
Measure: Deep vein thrombosis Time: During index hospital stay follow-up until 1 year after ECMO initiation
Measure: Pulmonary embolism Time: During index hospital stay follow-up until 1 year after ECMO initiation
Measure: Length of ICU stay Time: During index hospital stay follow-up until 1 year after ECMO initiation
Measure: Length of hospital stay Time: During index hospital stay follow-up until 1 year after ECMO initiation
Measure: Death after hospital discharge Time: During index hospital stay follow-up until 1 year after ECMO initiation
No related HPO nodes (Using clinical trials)